Cytosorbents
CTSO
#9880
Rank
C$59.08 M
Marketcap
C$0.94
Share price
-3.72%
Change (1 day)
-27.33%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -C$16.38 Million

According to Cytosorbents's latest financial reports the company's current earnings are C$36.1 Million. In 2024 the company made an earning of -C$30.68 Million, an increase over its 2023 earnings that were of -C$40.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$16.38 Million-46.62%
2024 -C$30.68 Million-23.97%
2023 -C$40.36 Million-13.52%
2022 -C$46.67 Million34.04%
2021 -C$34.82 Million182.17%
2020 -C$12.34 Million-55.97%
2019 -C$28.02 Million14.17%
2018 -C$24.54 Million95.14%
2017 -C$12.58 Million-22.32%
2016 -C$16.19 Million39.1%
2015 -C$11.64 Million-12.89%
2014 -C$13.36 Million89%
2013 -C$7.07 Million26.65%
2012 -C$5.59 Million-26.02%
2011 -C$7.55 Million-288.45%
2010 C$4 M-4.17%
2009 C$4.17 M-287.19%
2008 -C$2.24 Million-47.12%
2007 -C$4.23 Million41.78%
2006 -C$2.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Meridian Bioscience
VIVO
C$76.38 M-585.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
C$1.09 B-7,057.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
C$4.50 B-28,683.67%๐Ÿ‡บ๐Ÿ‡ธ USA